Jin-Hai Tang (Jinhai Tang)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 24

Top Venues

Nature communications

Cancer medicine

Bioscience reports

OncoTargets and therapy

the First Affiliated Hospital of Nanjing Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

the First Affiliated Hospital of Nanjing Medical University

China

surgeon/professor :: Department of General Surgery

Publications

Qing Li, Liren Zhang, Wenhua You, Jiali Xu, Jingjing Dai, Dongxu Hua, Ruizhi Zhang, Feifan Yao, Suiqing Zhou, Wei Huang, Yongjiu Dai, Yu Zhang, Tasiken Baheti, Xiaofeng Qian, Liyong Pu, Jing Xu, Yongxiang Xia, Chuanyong Zhang, Jin-Hai Tang, Xue-Hao Wang
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nature communications 13 (1) (2022)
Di Xu, Wen-Juan Tang, Yi-Zhi Zhu, Zhen Liu, Kai Yang, Ming-Xing Liang, Xiu Chen, Yang Wu, Jin-Hai Tang, Wei Zhang
Hyperthermia promotes exosome secretion by regulating Rab7b while increasing drug sensitivity in adriamycin-resistant breast cancer. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 39 (1) (2022)
Ningfei Ji, Mingshun Zhang, Liang Ren, Yunyun Wang, Bicheng Hu, Jie Xiang, Yingyun Gong, Chaojie Wu, Guoqiang Qu, Wenqiu Ding, Zhiqiang Yin, Shan Li, Zhengxia Wang, Lianzheng Zhou, Xueqin Chen, Yuan Ma, Jin-Hai Tang, Yun Liu, Liang Liu, Mao Huang
SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients. Emerging microbes & infections 11 (1) (2022)
Qing Li, Liren Zhang, Wenhua You, Jiali Xu, Jingjing Dai, Dongxu Hua, Ruizhi Zhang, Feifan Yao, Suiqing Zhou, Wei Huang, Yongjiu Dai, Yu Zhang, Tasiken Baheti, Xiaofeng Qian, Liyong Pu, Jing Xu, Yongxiang Xia, Chuanyong Zhang, Jin-Hai Tang, Xue-Hao Wang
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nature communications 13 (1) (2022)
Jia-Lin Xu, Qi Xu, Ya-Lin Wang, Di Xu, Wen-Xiu Xu, He-Da Zhang, Dan-Dan Wang, Jin-Hai Tang
Glucose metabolism and lncRNAs in breast cancer: Sworn friend. Cancer medicine (2022)
Qing Li, Liren Zhang, Wenhua You, Jiali Xu, Jingjing Dai, Dongxu Hua, Ruizhi Zhang, Feifan Yao, Suiqing Zhou, Wei Huang, Yongjiu Dai, Yu Zhang, Tasiken Baheti, Xiaofeng Qian, Liyong Pu, Jing Xu, Yongxiang Xia, Chuanyong Zhang, Jin-Hai Tang, Xue-Hao Wang
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nature communications 13 (1) (2022)
Dan-Dan Wang, Wen-Xiu Xu, Wen-Quan Chen, Lei Li, Su-Jin Yang, Jian Zhang, Jin-Hai Tang
Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A Comprehensive Pan-Cancer Analysis. Journal of oncology 2022 (2022)
Xin-Hui Cao, Xiu Chen, Kai Yang, Ya-Lin Wang, Ming-Xing Liang, Yin-Jiao Fei, Jin-Hai Tang
Vaspin accelerates the proliferation, invasion and metastasis of Triple-Negative breast cancer through MiR-33a-5p/ABHD2. Cancer medicine (2022)
Qing Li, Liren Zhang, Wenhua You, Jiali Xu, Jingjing Dai, Dongxu Hua, Ruizhi Zhang, Feifan Yao, Suiqing Zhou, Wei Huang, Yongjiu Dai, Yu Zhang, Tasiken Baheti, Xiaofeng Qian, Liyong Pu, Jing Xu, Yongxiang Xia, Chuanyong Zhang, Jin-Hai Tang, Xue-Hao Wang
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nature communications 13 (1) (2022)
Li Li, Da Wei, Junying Zhang, Rong Deng, Jin-Hai Tang, Dongming Su
miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer. Computational and mathematical methods in medicine 2022 (2022)
Yu-Xin Song, Zheng Xu, Ming-Xing Liang, Zhen Liu, Jun-Chen Hou, Xiu Chen, Di Xu, Yin-Jiao Fei, Jin-Hai Tang
Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta-analysis. Cancer medicine 11 (22) (2022)
Qing Li, Liren Zhang, Wenhua You, Jiali Xu, Jingjing Dai, Dongxu Hua, Ruizhi Zhang, Feifan Yao, Suiqing Zhou, Wei Huang, Yongjiu Dai, Yu Zhang, Tasiken Baheti, Xiaofeng Qian, Liyong Pu, Jing Xu, Yongxiang Xia, Chuanyong Zhang, Jin-Hai Tang, Xue-Hao Wang
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nature communications 13 (1) (2022)
Ming-Xing Liang, Yin-Jiao Fei, Kai Yang, Wen-Juan Tang, Xin-Hui Cao, Jin-Hai Tang
Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis. BMC cancer 22 (1) (2022)
Sai-Nan Ma, Zhi-Xiang Mao, Yang Wu, Ming-Xing Liang, Dan-Dan Wang, Xiu Chen, Ping-An Chang, Wei Zhang, Jin-Hai Tang
The anti-cancer properties of heparin and its derivatives: a review and prospect. Cell adhesion & migration 14 (1) (2021)
Shengnan Bao, Mengping Jiang, Xi Wang, Yijia Hua, Tianyu Zeng, Yiqi Yang, Fan Yang, Xueqi Yan, Chunxiao Sun, Mengzhu Yang, Ziyi Fu, Xiang Huang, Jun Li, Hao Wu, Wei Li, Jin-Hai Tang, Yongmei Yin
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based study. Cancer medicine 10 (23) (2021)
Xin-Hui Cao, Ming-Xing Liang, Yang Wu, Kai Yang, Jin-Hai Tang, Wei Zhang
Extracellular vesicles as drug vectors for precise cancer treatment. Nanomedicine (London, England) 16 (17) (2021)
Aijun Sun, Xiaonan Sheng, Jin-Hai Tang, Zhenfeng Yu, Jian Zhang
Integrated Bioinformatics and Experimental Approaches Identified the Role of NPPA in the Proliferation and the Malignant Behavior of Breast Cancer. Journal of immunology research 2021 (2021)
Lin Tang, Juan Jin, Kun Xu, Xin Wang, Jin-Hai Tang, Xiaoxiang Guan
SOX9 interacts with FOXC1 to activate MYC and regulate CDK7 inhibitor sensitivity in triple-negative breast cancer. Oncogenesis 9 (5) (2020)
Weilin Xu, Xiu Chen, Fei Deng, Jian Zhang, Wei Zhang, Jin-Hai Tang
Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review. OncoTargets and therapy 13 (2020)
He-da Zhang, Lin-Hong Jiang, Shan-Liang Zhong, Jian Li, Da-Wei Sun, Jun-Chen Hou, Dan-Dan Wang, Si-Ying Zhou, Jin-Hai Tang
The role of long non-coding RNAs in drug resistance of cancer. Clinical genetics 99 (1) (2020)
Wenxiu Xu, Yuting Hua, Fei Deng, Dandan Wang, Yang Wu, Wei Zhang, Jin-Hai Tang
MiR-145 in cancer therapy resistance and sensitivity: A comprehensive review. Cancer science 111 (9) (2020)
Hao Li, Wei Zhang, Li Ding, Xing-Wang Li, Yang Wu, Jin-Hai Tang
Prussian blue-modified ferritin nanoparticles for effective tumor chemo-photothermal combination therapy via enhancing reactive oxygen species production. Journal of biomaterials applications 33 (9) (2019)
Qian Zhang, Jin-Yan Wang, Wei Yan, Dan-Dan Wang, Su-Jin Yang, Si-Ying Zhou, Shan-Liang Zhong, Jin-Hai Tang
Clinical and pathological significance of Homo sapiens ceramide synthase 2 (CerS-2) in diverse human cancers. Bioscience reports 39 (5) (2019)
Si-Ying Zhou, Wei Chen, Su-Jin Yang, Zi-Han Xu, Jia-Hua Hu, He-da Zhang, Shan-Liang Zhong, Jin-Hai Tang
The emerging role of circular RNAs in breast cancer. Bioscience reports 39 (6) (2019)

Jin-Hai Tang.css-eqlu8i{font-size:small;padding-left:4px;} (Jinhai Tang)

Publication Activity (10 Years)

Top Topics

Top Venues

Jin-Hai Tang (Jinhai Tang)